Page last updated: 2024-09-05

ibogaine and Addiction, Opioid

ibogaine has been researched along with Addiction, Opioid in 20 studies

Research

Studies (20)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (10.00)	18.2507
2000's	4 (20.00)	29.6817
2010's	10 (50.00)	24.3611
2020's	4 (20.00)	2.80

Authors

Authors	Studies
Luz, M; Mash, DC	2
Belgers, M; Donders, R; Knuijver, T; Kramers, K; Schellekens, A; Verkes, RJ	1
Belgers, M; Donders, R; Knuijver, T; Kramers, K; Schellekens, A; van Oosteren, T; Verkes, R	1
Frampton, CM; Noller, GE; Yazar-Klosinski, B	1
Alper, K; Brown, TK	1
C Mash, D	1
Ameyaw, B; Farrow, SC; Kamileen, MO; Meades, J; O'Connor, SE; Xiao, Y	1
Belgers, M; Knuijver, T; Markus, W; Schellekens, A; van Oosteren, T; Verkes, RJ	1
Bussey, K; Caputi, L; Farrow, SC; Kamileen, MO; McAtee, RC; Mundy, JEA; O'Connor, SE; Stephenson, CRJ	1
Willyard, C	1
Cape, G; Devane, J; Friedhoff, L; Glue, P; Gray, A; Harland, S; Howes, J; Hung, CT; Hung, N; Lam, F; Lockhart, M; Tunnicliff, D; Weis, H	1
Cape, G; Crockett, RS; Darpo, B; Devane, J; Friedhoff, L; Glue, P; Harland, S; Howes, J; Hung, CT; Hung, N; Lam, F; Lockhart, M; Tunnicliff, D; Weis, H; Zhou, M	1
Gevirtz, C	1
Alper, KR; Glick, SD	1
Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP	1
Alper, KR; Kaplan, CD; Lotsof, HS	1
Bandarage, UK; Glick, SD; Kuehne, ME; Maisonneuve, IM; Molinari, HH	1
Badio, B; Daly, JW; Padgett, WL	1
Ali, SF; Baumann, MH; Mash, DC; Pablo, J; Rothman, RB	1

Reviews

2 review(s) available for ibogaine and Addiction, Opioid

Article	Year
Anesthesia for opiate detoxification and the ibogaine controversy. International anesthesiology clinics, 2011,Winter, Volume: 49, Issue:1 Topics: Anesthesia; Animals; Humans; Ibogaine; Opioid-Related Disorders	2011
Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine. The Alkaloids. Chemistry and biology, 2001, Volume: 56 Topics: Animals; Behavior, Animal; Brain; Corticosterone; Dopamine; Humans; Ibogaine; Opioid-Related Disorders; Serotonin	2001

Trials

2 trial(s) available for ibogaine and Addiction, Opioid

Article	Year
Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics. Journal of clinical pharmacology, 2016, Volume: 56, Issue:8 Topics: Adult; Analgesics, Opioid; Double-Blind Method; Drug Substitution; Female; Headache; Humans; Ibogaine; Male; Methadone; Morphine; Nausea; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome	2016
Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients. Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6 Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Ibogaine; Long QT Syndrome; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome	2016

Article

Year

Switching Opioid-Dependent Patients From Methadone to Morphine: Safety, Tolerability, and Methadone Pharmacokinetics.

Journal of clinical pharmacology, 2016, Volume: 56, Issue:8

Topics: Adult; Analgesics, Opioid; Double-Blind Method; Drug Substitution; Female; Headache; Humans; Ibogaine; Male; Methadone; Morphine; Nausea; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome

2016

Ascending Single-Dose, Double-Blind, Placebo-Controlled Safety Study of Noribogaine in Opioid-Dependent Patients.

Clinical pharmacology in drug development, 2016, Volume: 5, Issue:6

Topics: Adult; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Ibogaine; Long QT Syndrome; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome

2016

Other Studies

16 other study(ies) available for ibogaine and Addiction, Opioid

Article	Year
Reply to Knuijver et al. on the 'Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study'. Addiction (Abingdon, England), 2022, Volume: 117, Issue:3 Topics: Analgesics, Opioid; Humans; Ibogaine; Opioid-Related Disorders; Substance Withdrawal Syndrome	2022
Response to Luz & Mash on cardiac toxicity of ibogaine. Addiction (Abingdon, England), 2022, Volume: 117, Issue:3 Topics: Cardiotoxicity; Hallucinogens; Humans; Ibogaine; Opioid-Related Disorders	2022
Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study. Addiction (Abingdon, England), 2022, Volume: 117, Issue:1 Topics: Analgesics, Opioid; Data Collection; Humans; Ibogaine; Morphine; Opioid-Related Disorders	2022
Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse. Expert opinion on drug metabolism & toxicology, 2021, Volume: 17, Issue:9 Topics: Animals; Hallucinogens; Humans; Ibogaine; Opioid-Related Disorders	2021
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1 Topics: Adult; Depression; Female; Follow-Up Studies; Hallucinogens; Humans; Ibogaine; Male; Middle Aged; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome	2018
Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes. The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1 Topics: Adult; Female; Hallucinogens; Humans; Ibogaine; Male; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult	2018
Breaking the cycle of opioid use disorder with Ibogaine. The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1 Topics: Humans; Ibogaine; Opioid-Related Disorders	2018
Cytochrome P450 and The Journal of biological chemistry, 2018, 09-07, Volume: 293, Issue:36 Topics: Alkaloids; Catalysis; Cytochrome P-450 Enzyme System; High-Throughput Nucleotide Sequencing; Ibogaine; Opioid-Related Disorders; Protein O-Methyltransferase; Tabernaemontana; Transcriptome	2018
Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:6 Topics: Adult; Hallucinogens; Humans; Ibogaine; Male; Opioid-Related Disorders; Perceptual Disorders; Time Factors	2018
Biosynthesis of an Anti-Addiction Agent from the Iboga Plant. Journal of the American Chemical Society, 2019, 08-21, Volume: 141, Issue:33 Topics: Biosynthetic Pathways; Humans; Ibogaine; Opioid-Related Disorders; Psychotropic Drugs; Stereoisomerism; Tabernaemontana	2019
Pharmacotherapy: Quest for the quitting pill. Nature, 2015, Jun-25, Volume: 522, Issue:7557 Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins	2015
Psychotropic complementary medicines. The British journal of psychiatry : the journal of mental science, 2006, Volume: 188 Topics: Humans; Ibogaine; Opioid-Related Disorders; Phytotherapy; Plant Extracts; Substance Withdrawal Syndrome	2006
Client and counselor attitudes toward the use of medications for treatment of opioid dependence. Journal of substance abuse treatment, 2007, Volume: 32, Issue:2 Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome	2007
The ibogaine medical subculture. Journal of ethnopharmacology, 2008, Jan-04, Volume: 115, Issue:1 Topics: Data Collection; Hallucinogens; Humans; Ibogaine; Internet; Medicine, African Traditional; Opioid-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders	2008
18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats. Brain research, 1996, May-06, Volume: 719, Issue:1-2 Topics: Animals; Cerebellum; Cocaine; Dopamine; Female; Ibogaine; Limbic System; Morphine; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Self Administration; Tremor	1996
Ibogaine: a potent noncompetitive blocker of ganglionic/neuronal nicotinic receptors. Molecular pharmacology, 1997, Volume: 51, Issue:1 Topics: Animals; Carbachol; Dopamine; Ganglionic Blockers; Humans; Ibogaine; Male; Mice; Nicotinic Antagonists; Opioid-Related Disorders; PC12 Cells; Rats; Receptors, N-Methyl-D-Aspartate	1997